Parkman Healthcare Partners LLC Standard Biotools Inc. Transaction History

Parkman Healthcare Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.87 - $2.78 $1.99 Million - $2.97 Million	1,066,781 Added 176.73%	1,670,401 $4.53 Million
Q4 2023 Feb 14, 2024	BUY	$1.59 - $2.73 $164,755 - $282,882	103,620 Added 20.72%	603,620 $1.33 Million
Q3 2023 Nov 14, 2023	BUY	$1.9 - $3.05 $950,000 - $1.53 Million	500,000 New	500,000 $1.45 Million
Q2 2020 Aug 13, 2020	SELL	$1.85 - $5.29 $416,973 - $1.19 Million	-225,391 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$1.24 - $4.35 $216,515 - $759,549	-174,609 Reduced 43.65%	225,391 $572,000
Q4 2019 Feb 13, 2020	BUY	$2.3 - $5.12 $919,999 - $2.05 Million	400,000 New	400,000 $1.39 Million

143

279M

27.2K

34.1K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $131M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Parkman Healthcare Partners LLC with notifications on news.